Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice

Neuroscience Letters

Volumn 517, Issue 1, 2012, Pages 7-12

  Euler, Philipp ^a   Friedrich, Bernd ^a   Ziegler, Ruhtraut ^a   Kuhn, Alexandre ^b   Lindenberg, Katrin S ^c   Weiller, Cornelius ^a   Zucker, Birgit ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b EPFL   (Switzerland)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Gene expression; Huntington's Disease; Laser Capture Microdissection; Purkinje cell; Real time quantitative PCR; Retinoid acid receptor related orphan receptor

Indexed keywords

ATAXIN 1; CALBINDIN; CARBONATE DEHYDRATASE; CATHEPSIN S; DIACYLGLYCEROL KINASE; DNA; EXCITATORY AMINO ACID TRANSPORTER 4; GLUTAMATE RECEPTOR 3; HIPPOCALCIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LIPOPROTEIN LIPASE; MESSENGER RNA; MYOSIN BINDING PROTEIN C; PENTRAXIN; PHOSPHOLIPASE C BETA3; PHOSPHOLIPASE C GAMMA; RETINOID RELATED ORPHAN RECEPTOR ALPHA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SOMATOMEDIN BINDING PROTEIN 5; SPECTRIN; SYNAPTOJANIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SINGLE CELL ANALYSIS;

ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; PURKINJE CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINOCEREBELLAR ATAXIAS;

EID: 84860572836     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.080     Document Type: Article

References (30)

1. 2+ homeostasis. J. Biol. Chem. 2008, 283(28):19854-19863.
2. Boukhtouche F., Janmaat S., Vodjdani G., Gautheron V., Mallet J., Dusart I., Mariani J. Retinoid-related orphan receptor alpha controls the early steps of Purkinje cell dendritic differentiation. J. Neurosci. 2006, 26(5):1531-1538.
3. Burright E.N., Clark H.B., Servadio A., Matilla T., Feddersen R.M., Yunis W.S., Duvick L.A., Zoghbi H.Y., Orr H.T. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995, 82(6):937-948.
4. Cha J.H. Transcriptional signatures in Huntington's disease. Prog. Neurobiol. 2007, 83(4):228-248.
5. Doulazmi M., Capone F., Frederic F., Bakouche J., Lemaigre-Dubreuil Y., Mariani J. Cerebellar purkinje cell loss in heterozygous rora+/- mice: a longitudinal study. J. Neurogenet. 2006, 20(1-2):1-17.
6. Empson R.M., Turner P.R., Nagaraja R.Y., Beesley P.W., Knopfel T. Reduced expression of the Ca(2+) transporter protein PMCA2 slows Ca(2+) dynamics in mouse cerebellar Purkinje neurones and alters the precision of motor coordination. J. Physiol. 2010, 588(Pt 6):907-922.
7. Ferrante R.J., Kubilus J.K., Lee J., Ryu H., Beesen A., Zucker B., Smith K., Kowall N.W., Ratan R.R., Luthi-Carter R., Hersch S.M. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci. 2003, 23(28):9418-9427.
8. Gehrking K.M., Andresen J.M., Duvick L., Lough J., Zoghbi H.Y., Orr H.T. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model. Hum. Mol. Genet. 2011, 20(11):2204-2212.
9. Ginsberg S.D., Elarova I., Ruben M., Tan F., Counts S.E., Eberwine J.H., Trojanowski J.Q., Hemby S.E., Mufson E.J., Che S. Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem. Res. 2004, 29(6):1053-1064.
10. Godin J.D., Poizat G., Hickey M.A., Maschat F., Humbert S. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease. EMBO J. 2010, 29(14):2433-2445.
11. Gold D.A., Baek S.H., Schork N.J., Rose D.W., Larsen D.D., Sachs B.D., Rosenfeld M.G., Hamilton B.A. RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways. Neuron 2003, 40(6):1119-1131.
12. Gold D.A., Gent P.M., Hamilton B.A. ROR alpha in genetic control of cerebellum development: 50 staggering years. Brain Res. 2007, 1140:19-25.
13. Gray E.G. The granule cells, mossy synapses and Purkinje spine synapses of the cerebellum: light and electron microscope observations. J. Anat. 1961, 95:345-356.
14. 2+ signaling in Purkinje neurons. Cell Calcium 2005, 37(5):459-466.
15. Helmlinger D., Hardy S., Abou-Sleymane G., Eberlin A., Bowman A.B., Gansmuller A., Picaud S., Zoghbi H.Y., Trottier Y., Tora L., Devys D. Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol. 2006, 4(3):e67.
16. Jeste D.V., Barban L., Parisi J. Reduced Purkinje cell density in Huntington's disease. Exp. Neurol. 1984, 85(1):78-86.
17. Luthi-Carter R., Hanson S.A., Strand A.D., Bergstrom D.A., Chun W., Peters N.L., Woods A.M., Chan E.Y., Kooperberg C., Krainc D., Young A.B., Tapscott S.J., Olson J.M. Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet. 2002, 11(17):1911-1926.
18. Macdonald M.E., Ambrose C.M., Duyao M.P., Myers R.H., Lin C., Srinidhi L., Barnes G., Taylor S.A., James M., Groot N., MacFarlane H., Jenkins B., Anderson M.A., Wexler N.S., Gusella J.F. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72(6):971-983.
19. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87(3):493-506.
20. Mccullough S.D., Grant P.A. Histone acetylation, acetyltransferases, and ataxia - alteration of histone acetylation and chromatin dynamics is implicated in the pathogenesis of polyglutamine-expansion disorders. Adv. Protein Chem. Struct. Biol. 2010, 79:165-203.
21. Merida I., Avila-Flores A., Merino E. Diacylglycerol kinases: at the hub of cell signalling. Biochem. J. 2008, 409(1):1-18.
22. Rodda R.A. Cerebellar atrophy in Huntington's disease. J. Neurol. Sci. 1981, 50(1):147-157.
23. Schaller K.L., Caldwell J.H. Expression and distribution of voltage-gated sodium channels in the cerebellum. Cerebellum 2003, 2(1):2-9.
24. Serra H.G., Duvick L., Zu T., Carlson K., Stevens S., Jorgensen N., Lysholm A., Burright E., Zoghbi H.Y., Clark H.B., Andresen J.M., Orr H.T. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 2006, 127(4):697-708.
25. Servadio A., Koshy B., Armstrong D., Antalffy B., Orr H.T., Zoghbi H.Y. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat. Genet. 1995, 10(1):94-98.
26. Steffan J.S., Bodai L., Pallos J., Poelman M., Mccampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greenwald M., Kurokawa R., Housman D.E., Jackson G.R., Marsh J.L., Thompson L.M. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001, 413(6857):739-743.
27. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G.P., Davies S.W. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(14):8093-8097.
28. Yuzaki M. The delta2 glutamate receptor: a key molecule controlling synaptic plasticity and structure in Purkinje cells. Cerebellum 2004, 3(2):89-93.
29. Zucker B., Kama J.A., Kuhn A., Thu D., Orlando L.R., Dunah A.W., Gokce O., Taylor D.M., Lambeck J., Friedrich B., Lindenberg K.S., Faull R.L., Weiller C., Young A.B., Luthi-Carter R. Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease. J. Neuropathol. Exp. Neurol. 2010, 69(9):880-895.
30. Zucker B., Luthi-Carter R., Kama J.A., Dunah A.W., Stern E.A., Fox J.H., Standaert D.G., Young A.B., Augood S.J. Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1. Hum. Mol. Genet. 2005, 14(2):179-189.